These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2441203)

  • 21. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
    Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G
    Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial.
    Boccanelli A; Zachara E; Liberatore SM; Carboni GP; Prati PL
    Postgrad Med J; 1986; 62 Suppl 1():184-7. PubMed ID: 3534859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.
    Brouwer J; van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Boomsma F; Haaksma J; Lie KI
    J Am Coll Cardiol; 1995 Oct; 26(4):983-90. PubMed ID: 7560628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term use of K-strophanthin in advanced congestive heart failure due to dilated cardiomyopathy: a double-blind crossover evaluation versus digoxin.
    Agostoni PG; Doria E; Berti M; Guazzi MD
    Clin Cardiol; 1994 Oct; 17(10):536-41. PubMed ID: 8001300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Captopril pharmacokinetics and the acute hemodynamic and hormonal response in patients with severe chronic congestive heart failure.
    Cody RJ; Covit A; Schaer G; Williams G
    Am Heart J; 1982 Nov; 104(5 Pt 2):1180-3. PubMed ID: 6291363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
    Cody RJ; Laragh JH
    Am Heart J; 1982 Nov; 104(5 Pt 2):1184-9. PubMed ID: 6291364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
    Sharpe DN; Coxon R
    Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The level of plasma neuroendocrine activity and the concentration of digoxin in the serum of patients with mild chronic heart failure.
    Jablecka A; Chmara E; Korzeniowska K
    Int J Clin Pharmacol Res; 1998; 18(4):171-8. PubMed ID: 10052027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
    Giles TD; Katz R; Sullivan JM; Wolfson P; Haugland M; Kirlin P; Powers E; Rich S; Hackshaw B; Chiaramida A
    J Am Coll Cardiol; 1989 May; 13(6):1240-7. PubMed ID: 2539403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the immediate and long-term effects of captopril and isosorbide dinitrate as adjunctive treatment in mild heart failure.
    Wilkes NP; Barin E; Hoschl R; Stokes GS; Nelson GI
    Br J Clin Pharmacol; 1989 Oct; 28(4):427-34. PubMed ID: 2686737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
    Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
    Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment.
    Riegger GA; Haeske W; Kraus C; Kromer EP; Kochsiek K
    Am J Cardiol; 1987 Apr; 59(8):906-10. PubMed ID: 3548307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Weiner DA; Ryan TJ
    Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
    Riegger GA; Kochsiek K
    Am J Cardiol; 1986 Aug; 58(3):300-3. PubMed ID: 3526857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
    Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
    Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognosis of mild chronic heart failure: effects of the ACE inhibitor captopril].
    Kleber FX; Doering W
    Herz; 1991 Sep; 16 Spec No 1():283-93. PubMed ID: 1820294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of treatment with vasodilators on physical exercise tolerance in patients with chronic congestive heart failure].
    Markiewicz K; Górski L; Broks-Bratkowska B; Cholewa M
    Pol Tyg Lek; 1993 Jan 18-25; 48(3-4):61-4. PubMed ID: 8361890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure.
    Corbalán R; Jalil J; Chamorro G; Casanegra P; Valenzuela P
    Am J Cardiol; 1990 Mar; 65(9):644-9. PubMed ID: 2178384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.